BOOK
Practical Pulmonary Pathology: A Diagnostic Approach E-Book
Kevin O. Leslie | Mark R. Wick
(2017)
Additional Information
Book Details
Abstract
Part of the in-depth and practical Pattern Recognition series, Practical Pulmonary Pathology, 3rd Edition, helps you accurately identify and interpret neoplastic and non-neoplastic diseases of the lungs by using a pattern-based approach. Leading diagnosticians in pulmonary pathology guide you from a histological pattern, through the appropriate work-up, around the pitfalls, and to the best diagnosis. Superb, full-color illustrations capture key pathological patterns for a full range of common and rare conditions, and a "visual index" at the beginning of the book directs you to the exact location of in-depth diagnostic guidance.
A user-friendly design color-codes patterns to specific entities, and key points are summarized in tables, charts, and graphs so you can quickly and easily find what you are looking for.
- Sweeping content updates keep you at the forefront of recent findings regarding pulmonary hypertension, pediatric lung disease, and all major neoplastic and non-neoplastic diseases of the lung.
- A new chapter on Pulmonary Function Testing for Pathologists brings you up to date with relevant aspects of these key tests.
- Improved pattern call-outs are now linked directly within the chapter, reinforcing the patterns for more efficient and complete understanding.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
Half title page | i | ||
Pattern Recognition Series | ii | ||
Practical Pulmonary Pathology: A Diagnostic Approach | iii | ||
Copyright Page | iv | ||
Dedication | v | ||
Contributors | vii | ||
Series Preface | ix | ||
Preface | xi | ||
Table Of Contents | xiii | ||
Pattern-Based Approach to Diagnosis | xv | ||
Pattern 1 Acute Lung Injury | xviii | ||
Pattern 2 Fibrosis | xx | ||
Pattern 3 Chronic Cellular Infiltrates | xxii | ||
Pattern 4 Alveolar Filling | xxiv | ||
Pattern 5 Nodules | xxvi | ||
Pattern 6 Nearly Normal Lung | xxix | ||
1 Lung Anatomy | 1 | ||
Development and Gross Anatomy | 1 | ||
Airway Development | 1 | ||
Pleura | 1 | ||
Lung Lobes | 1 | ||
Microscopic Anatomy | 5 | ||
Conducting Airways | 5 | ||
Trachea | 5 | ||
Bronchi | 5 | ||
Bronchioles | 5 | ||
Airway Mucosal Neuroendocrine Cells | 5 | ||
Airway-Associated Lymphoid Tissue | 6 | ||
Epithelial Basement Membrane | 7 | ||
Smooth Muscle of the Airways | 7 | ||
Acinus | 7 | ||
Alveoli | 8 | ||
Alveolar Walls | 8 | ||
Alveolar Macrophages | 8 | ||
Pulmonary Arteries | 8 | ||
Pulmonary Veins | 9 | ||
Bronchial Arteries | 10 | ||
Pulmonary Lymphatics | 11 | ||
Other Pulmonary Lymphoid Tissue | 11 | ||
Lymphoid Aggregates | 11 | ||
Dendritic Cells | 11 | ||
References | 13 | ||
Multiple Choice Questions | 14.e1 | ||
2 Pulmonary Function Testing for Pathologists | 15 | ||
Lung Volumes | 15 | ||
Tools to Measure Volumes | 16 | ||
Interpretation of Lung Volumes | 17 | ||
Flows | 17 | ||
Airway Resistance | 17 | ||
Respiratory Muscle Strength | 17 | ||
Diffusion Capacity | 18 | ||
Summary | 19 | ||
References | 19 | ||
Multiple Choice Questions | 20.e1 | ||
Case 1 | 20.e3 | ||
3 Optimal Processing of Diagnostic Lung Specimens | 21 | ||
Specimens Obtained Through the Flexible Bronchoscope | 21 | ||
Endobronchial Biopsy | 21 | ||
Transbronchial Biopsy | 22 | ||
Cryobiopsy | 25 | ||
Bronchial Brushings | 26 | ||
Bronchial Washings and Bronchoalveolar Lavage | 26 | ||
Transbronchial Fine-Needle Aspiration | 28 | ||
Endobronchial Ultrasound–Guided Biopsy | 29 | ||
Rigid Bronchoscopy | 29 | ||
Specimens Obtained by Transthoracic Needle Biopsy and Aspiration | 29 | ||
Thoracentesis | 29 | ||
Closed Pleural Biopsy | 29 | ||
Transthoracic Fine-Needle Core Aspiration and Biopsy of the Lung | 29 | ||
Specimens Obtained by Thoracoscopy | 30 | ||
Specimen Processing | 30 | ||
Conclusion | 31 | ||
References | 33 | ||
Multiple Choice Questions | 34.e1 | ||
Case 1 | 34.e2 | ||
Transbronchial biopsy with sponge artifact (eSlide 3.1) | 34.e2 | ||
Case 2 | 34.e3 | ||
Cryobiopsy with diagnosable interstitial lung disease (eSlide 3.2) | 34.e3 | ||
Case 3 | 34.e3 | ||
Endobronchial ultrasound–guided fine-needle aspiration with adenocarcinoma (eSlide 3.3) | 34.e3 | ||
Case 4 | 34.e3 | ||
Needle biopsy with mucinous adenocarcinoma (eSlide 3.4) | 34.e3 | ||
Case 5 | 34.e3 | ||
Poorly processed video-assisted thoracic surgery biopsy with crush and atelectasis (eSlide 3.5) | 34.e3 | ||
4 Computed Tomography of Diffuse Lung Diseases and Solitary Pulmonary Nodules | 35 | ||
Foundations | 35 | ||
Living With X-Rays and Working With Computed Tomography | 35 | ||
X-Rays and Computed Tomography | 35 | ||
Computed Tomography, Spiral Computed Tomography, and High-Resolution Computed Tomography | 35 | ||
Terminology | 36 | ||
Lung Anatomy | 37 | ||
Arteries, Veins, and Bronchi | 37 | ||
Secondary Lobule | 38 | ||
Special Techniques | 38 | ||
Increasing Visibility | 38 | ||
Multiplanar Reformation. | 38 | ||
Curved Multiplanar Reformation. | 39 | ||
Increasing Ambience | 39 | ||
Maximum Intensity Projection. | 39 | ||
Minimum Intensity Projection. | 39 | ||
Volume Rendering. | 40 | ||
Prone and Expiratory Computed Tomography | 40 | ||
Diffuse Lung Diseases | 40 | ||
Elementary Lesions | 40 | ||
Patterns | 40 | ||
Septal Pattern | 41 | ||
Definition | 41 | ||
High-Resolution Computed Tomography Signs | 41 | ||
Subsets | 43 | ||
Subset Smooth | 43 | ||
Interstitial Hydrostatic Pulmonary Edema. | 43 | ||
Lymphangitic Carcinomatosis. | 45 | ||
Venoocclusive Disease. | 46 | ||
Erdheim-Chester Disease. | 46 | ||
Subset Nodular | 46 | ||
Diffuse Interstitial Amyloidosis. | 47 | ||
Fibrotic Pattern | 48 | ||
Definition | 48 | ||
High-Resolution Computed Tomography Signs | 48 | ||
Subsets | 49 | ||
Subset Usual Interstitial Pneumonia | 49 | ||
Asbestosis. | 49 | ||
Chronic Hypersensitivity Pneumonitis. | 50 | ||
Idiopathic Usual Interstitial Pneumonia–Clinical Idiopathic Pulmonary Fibrosis. | 52 | ||
Subset Fibrotic Nonspecific Interstitial Pneumonia | 53 | ||
Idiopathic Fibrotic Nonspecific Interstitial Pneumonia. | 53 | ||
Subset Tug-of-War | 54 | ||
Sarcoidosis, Chronic. | 54 | ||
Pleuroparenchymal Fibroelastosis. | 56 | ||
Subset Bronchocentric Fibrosis | 56 | ||
Airway-Centered Interstitial Fibrosis. | 56 | ||
Nodular Pattern | 57 | ||
Definition | 57 | ||
High-Resolution Computed Tomography Signs | 57 | ||
Subsets | 58 | ||
Subset Centrilobular | 58 | ||
Follicular Bronchiolitis. | 59 | ||
Subacute Hypersensitivity Pneumonitis. | 59 | ||
Respiratory Bronchiolitis–Interstitial Lung Disease. | 60 | ||
Subset Lymphatic | 61 | ||
Sarcoidosis. | 62 | ||
Lymphoid Interstitial Pneumonia. | 62 | ||
Silicosis and Coal Worker’s Pneumoconiosis. | 63 | ||
Subset Random | 64 | ||
Hematogenous Metastases. | 64 | ||
Miliary Tuberculosis. | 65 | ||
Alveolar Pattern | 66 | ||
Definition | 66 | ||
High-Resolution Computed Tomography Signs | 67 | ||
Subsets | 68 | ||
Subset Acute | 68 | ||
Acute Interstitial Pneumonia/Acute Respiratory Distress Syndrome. | 68 | ||
Acceleration (Acute Exacerbation) of Fibrosing Diseases. | 69 | ||
Diffuse Alveolar Hemorrhage. | 69 | ||
Hydrostatic Pulmonary Edema. | 70 | ||
Infectious Diseases. | 70 | ||
Subset Chronic | 72 | ||
Adenocarcinoma. | 72 | ||
Chronic Eosinophilic Pneumonia. | 73 | ||
Desquamative Interstitial Pneumonia. | 74 | ||
Infectious and Inflammatory Diseases. | 74 | ||
Mucosa-Associated Lymphoid Tissue Lymphoma. | 75 | ||
Cellular Nonspecific Interstitial Pneumonia. | 75 | ||
Organizing Pneumonia. | 76 | ||
Pulmonary Alveolar Proteinosis. | 77 | ||
Cystic Pattern | 77 | ||
Definition | 77 | ||
High-Resolution Computed Tomography Signs | 79 | ||
Centrilobular Emphysema | 81 | ||
Langerhans Cell Histiocytosis | 81 | ||
Laryngotracheobronchial Papillomatosis | 82 | ||
Lymphangioleiomyomatosis | 83 | ||
Cystic Metastases | 84 | ||
Birt-Hogg-Dubé Syndrome | 84 | ||
Dark Lung Pattern | 85 | ||
Definition | 85 | ||
High-Resolution Computed Tomography Signs | 85 | ||
Chronic Pulmonary Thromboembolism | 86 | ||
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia | 88 | ||
Constrictive Bronchiolitis | 88 | ||
Panlobular Emphysema | 89 | ||
Swyer-James (MacLeod Syndrome) | 89 | ||
Imaging of the Solitary Pulmonary Nodule | 90 | ||
Rationale for the Diagnostic Approach | 90 | ||
Static Elements | 91 | ||
Risk Factors | 91 | ||
Morphologic Aspects | 91 | ||
Computed Tomography Densitometry | 92 | ||
Cavitation and Air Bronchogram | 92 | ||
Dynamic Elements | 92 | ||
Doubling Time | 92 | ||
Computed Tomography Contrast Enhancement | 93 | ||
Positron Emission Tomography Metabolism | 93 | ||
References | 93 | ||
Multiple Choice Questions | 98.e1 | ||
Case 1 | 98.e2 | ||
As a Distorted Fine Net | 98.e2 | ||
Short History | 98.e2 | ||
High-Resolution Computed Tomography (eSlide 4.1A,B,C) | 98.e2 | ||
Histologic Examination (eSlide 4.1D,E) | 98.e2 | ||
Diagnosis | 98.e2 | ||
5 Developmental and Pediatric Lung Disease | 99 | ||
Processing of Pediatric Lung Biopsy Specimens | 99 | ||
Processing of Pediatric Cystic Lung Lesion Specimens | 100 | ||
Cysts and Masses | 100 | ||
Bronchogenic Cysts | 100 | ||
Bronchial Atresia | 101 | ||
Pulmonary Sequestration | 101 | ||
Extralobar Sequestration | 102 | ||
Intralobar Sequestration | 102 | ||
Congenital Pulmonary Airway Malformations | 103 | ||
Pulmonary Interstitial Emphysema | 104 | ||
Peripheral Cysts Secondary to Lung Maldevelopment | 105 | ||
Pulmonary Hyperlucency | 105 | ||
Congenital Lobar Overinflation | 105 | ||
Polyalveolar Lobe | 105 | ||
Disorders of Lung Development | 106 | ||
Acinar Dysplasia | 106 | ||
Congenital Alveolar Dysplasia | 106 | ||
Pulmonary Hypoplasia | 107 | ||
Pulmonary Hyperplasia | 107 | ||
Vascular Disorders | 108 | ||
Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins | 108 | ||
Congenital Pulmonary Lymphangiectasis | 108 | ||
Diffuse Pulmonary Lymphangiomatosis | 110 | ||
Pulmonary Arteriovenous Malformations | 110 | ||
Complications of Prematurity | 110 | ||
Hyaline Membrane Disease | 110 | ||
Bronchopulmonary Dysplasia | 110 | ||
Pediatric Interstitial Lung Disease | 111 | ||
Alveolar Growth Abnormalities | 111 | ||
Pulmonary Interstitial Glycogenosis (Infantile Cellular Interstitial Pneumonitis) | 113 | ||
Genetic Disorders of Surfactant Metabolism | 114 | ||
Pulmonary Alveolar Proteinosis | 114 | ||
Chronic Pneumonitis of Infancy | 115 | ||
Desquamative Interstitial Pneumonia | 115 | ||
Nonspecific Interstitial Pneumonia | 115 | ||
Lymphocytic Interstitial Pneumonia and Follicular Bronchiolitis | 116 | ||
Hypersensitivity Pneumonitis (Extrinsic Allergic Alveolitis) | 116 | ||
Eosinophilic Pneumonia | 116 | ||
Aspiration Injury | 116 | ||
Obliterative Bronchiolitis | 120 | ||
Neuroendocrine Cell Hyperplasia of Infancy (Persistent Tachypnea of Infancy) | 120 | ||
Storage Disorders | 120 | ||
Vascular Disease as a Cause of Interstitial Lung Disease | 120 | ||
Hemorrhage Syndromes in Children | 120 | ||
References | 121 | ||
Multiple Choice Questions | 124.e1 | ||
Case 1 | 124.e2 | ||
eSlide 5.1 | 124.e2 | ||
Clinical History | 124.e2 | ||
Virtual Slide Microscopic Findings | 124.e2 | ||
Diagnosis | 124.e2 | ||
6 Acute Lung Injury | 125 | ||
Diffuse Alveolar Damage: The Morphologic Prototype of Acute Lung Injury | 125 | ||
Specific Causes of Acute Lung Injury | 128 | ||
Infection | 128 | ||
Viral Infection | 129 | ||
Fungal Infection | 133 | ||
Bacterial Infection | 133 | ||
Connective Tissue Disease | 134 | ||
Systemic Lupus Erythematosus | 135 | ||
Rheumatoid Arthritis | 135 | ||
Polymyositis/Dermatomyositis | 136 | ||
Drug Effect | 136 | ||
Chemotherapeutic Agents | 136 | ||
Amiodarone | 138 | ||
Antiinflammatory Drugs | 139 | ||
Acute Eosinophilic Pneumonia | 139 | ||
Acute Interstitial Pneumonia | 140 | ||
Immunologically Mediated Pulmonary Hemorrhage and Vasculitis | 140 | ||
Radiation Pneumonitis | 140 | ||
Disease Presenting as Classic Acute Respiratory Distress Syndrome | 140 | ||
Oxygen Toxicity and Inhalants | 141 | ||
Shock and Trauma | 141 | ||
Ingested Toxins | 142 | ||
Pathologist Approach to the Differential Diagnosis of Acute Lung Injury | 142 | ||
Clinicopathologic Correlation | 143 | ||
References | 144 | ||
Multiple Choice Questions | 146.e1 | ||
Case 1 | 146.e2 | ||
Diffuse alveolar damage with hyaline membranes (eSlide 6.1) | 146.e2 | ||
Case 2 | 146.e2 | ||
Acute and fibrinous organizing pneumonia (eSlide 6.2) | 146.e2 | ||
Case 3 | 146.e3 | ||
Acute lupus pneumonitis (eSlide 6.3) | 146.e3 | ||
Case 4 | 146.e3 | ||
Amiodarone-induced diffuse alveolar damage (eSlide 6.4) | 146.e3 | ||
Case 5 | 146.e3 | ||
Acute eosinophilic pneumonia (eSlide 6.5) | 146.e3 | ||
7 Lung Infections | 147 | ||
Diagnostic Tools and Strategies | 147 | ||
Knowledge of the Clinical Setting | 148 | ||
Pattern Recognition | 150 | ||
Useful Tissue Stains in Lung Infection | 152 | ||
Immunologic and Molecular Techniques | 153 | ||
Limiting Factors in Diagnosis | 153 | ||
Role of Cytopathologic Examination in Diagnosis of Lung Infection | 157 | ||
Summary | 158 | ||
Bacterial Pneumonias | 159 | ||
Etiologic Agents | 159 | ||
Histopathology | 160 | ||
Acute Exudative Pneumonia | 160 | ||
Nodular/Necrotizing Lesions | 160 | ||
Miliary Lesions | 161 | ||
Aspiration Pneumonia and Lung Abscess | 161 | ||
Chronic Bacterial Pneumonias | 162 | ||
Bacterial Agents of Bioterrorism | 164 | ||
Bacillus anthracis | 164 | ||
Yersinia pestis | 165 | ||
Francisella tularensis | 166 | ||
Cytopathology | 166 | ||
Microbiology | 166 | ||
Differential Diagnosis | 170 | ||
Mycobacterial Infections | 171 | ||
Etiologic Agents | 171 | ||
Mycobacterium tuberculosis | 171 | ||
Nontuberculous Mycobacteria | 172 | ||
Histopathology | 172 | ||
Primary Tuberculosis | 172 | ||
Postprimary Tuberculosis | 173 | ||
Tuberculous Pleurisy | 174 | ||
Nontuberculous Mycobacterial Infections | 174 | ||
Cytopathology | 176 | ||
Microbiology | 176 | ||
Fungal Pneumonias | 178 | ||
Etiologic Agents | 178 | ||
Histopathology | 178 | ||
Blastomycosis | 179 | ||
Coccidioidomycosis | 180 | ||
Histoplasmosis | 180 | ||
Paracoccidioidomycosis (South American Blastomycosis) | 182 | ||
Sporotrichosis | 182 | ||
Penicilliosis | 182 | ||
Cryptococcosis | 184 | ||
Candidiasis | 185 | ||
Aspergillosis | 187 | ||
Zygomycosis | 188 | ||
Phaeohyphomycosis | 190 | ||
Pneumocystosis | 191 | ||
Cytopathology | 193 | ||
Cytology of Common Yeast Forms | 193 | ||
Cytology of Common Mycelial Forms | 193 | ||
Microbiology | 195 | ||
Differential Diagnosis | 197 | ||
Viral Pneumonia | 199 | ||
Etiologic Agents | 199 | ||
Histopathology | 199 | ||
Influenza Virus | 199 | ||
Parainfluenza Virus | 200 | ||
Respiratory Syncytial Virus | 201 | ||
Human Metapneumovirus | 201 | ||
Measles Virus | 201 | ||
Hantavirus | 202 | ||
Coronaviruses | 202 | ||
Adenovirus | 203 | ||
Herpes Simplex Viruses | 203 | ||
Varicella-Zoster Virus | 205 | ||
Cytomegalovirus | 205 | ||
Epstein–Barr Virus | 205 | ||
Cytopathology | 206 | ||
Microbiology | 206 | ||
Differential Diagnosis | 209 | ||
Parasitic Infections | 209 | ||
Etiologic Agents | 209 | ||
Histopathology | 209 | ||
Toxoplasmosis | 211 | ||
Amebiasis | 211 | ||
Cryptosporidiosis | 211 | ||
Microsporidiosis | 212 | ||
Leishmaniasis | 212 | ||
Dirofilariasis | 212 | ||
Strongyloidiasis | 213 | ||
Echinococcosis | 214 | ||
Paragonimiasis | 214 | ||
Schistosomiasis | 214 | ||
Visceral Larva Migrans | 215 | ||
Cytopathology | 217 | ||
Microbiology | 217 | ||
Differential Diagnosis | 218 | ||
References | 219 | ||
Multiple Choice Questions | 226.e1 | ||
Case 1 | 226.e5 | ||
8 Chronic Diffuse Lung Diseases | 227 | ||
Idiopathic Interstitial Pneumonias | 228 | ||
Usual Interstitial Pneumonia | 229 | ||
Clinical Presentation | 230 | ||
Radiologic Findings | 230 | ||
Histopathologic Findings | 230 | ||
Acute Exacerbation | 234 | ||
Differential Diagnosis | 234 | ||
Clinical Course | 234 | ||
Essential Requirements for Accurate Diagnosis | 235 | ||
Familial Idiopathic Pulmonary Fibrosis | 235 | ||
Nonspecific Interstitial Pneumonia | 235 | ||
Clinical Presentation | 236 | ||
Radiologic Findings | 236 | ||
Histopathologic Findings | 236 | ||
Differential Diagnosis | 236 | ||
Clinical Course | 237 | ||
Cryptogenic Organizing Pneumonia | 237 | ||
Clinical Presentation | 238 | ||
Radiologic Findings | 239 | ||
Histopathologic Findings | 239 | ||
Treatment and Prognosis | 239 | ||
Differential Diagnosis | 239 | ||
Respiratory Bronchiolitis–Associated Interstitial Lung Disease | 240 | ||
Clinical Presentation | 240 | ||
Radiologic Findings | 240 | ||
Histopathologic Findings | 241 | ||
Differential Diagnosis | 242 | ||
Clinical Course | 242 | ||
Desquamative Interstitial Pneumonia | 242 | ||
Clinical Presentation | 243 | ||
Radiologic Findings | 243 | ||
Histopathologic Findings | 243 | ||
Differential Diagnosis | 244 | ||
Clinical Course | 244 | ||
Lymphoid Interstitial Pneumonia | 244 | ||
Clinical Presentation | 244 | ||
Radiologic Findings | 244 | ||
Histopathologic Findings | 245 | ||
Differential Diagnosis | 245 | ||
9 Nonneoplastic Pathology of the Large and Small Airways | 299 | ||
Large Airways: Trachea and Bronchi | 299 | ||
Trachea | 299 | ||
Tracheobronchial Amyloidosis | 299 | ||
Tracheobronchomalacia | 299 | ||
Tracheobronchomegaly | 301 | ||
Tracheobronchopathia Osteochondroplastica | 301 | ||
Bronchi | 302 | ||
Bronchitis | 302 | ||
Bronchiectasis | 302 | ||
Middle Lobe Syndrome | 303 | ||
Small Airways | 304 | ||
Inflammatory Bronchiolitis | 306 | ||
Acute Bronchiolitis | 306 | ||
Acute and Chronic Bronchiolitis | 306 | ||
Chronic Bronchiolitis | 307 | ||
Granulomatous Bronchiolitis | 308 | ||
Bronchiolar Necrosis | 312 | ||
Respiratory (Smoker’s) Bronchiolitis | 312 | ||
Peribronchiolar Metaplasia (Lambertosis) | 314 | ||
Mucostasis | 317 | ||
Bronchiolar Smooth Muscle Hyperplasia | 317 | ||
Fibrous Proliferations in and Around Bronchioles | 317 | ||
Bronchiolitis Obliterans Syndrome | 319 | ||
Terminal Airway Fibrosis With Dust Deposition (Pneumoconiosis-Associated Small Airway Disease) | 320 | ||
Dilated and Irregular Bronchiolar Shapes | 322 | ||
Bronchiolocentric Nodules | 322 | ||
Clinicopathologic Entities With Prominent Airway Manifestations | 323 | ||
Asthma-Associated Airway Diseases | 323 | ||
Allergic Bronchopulmonary Fungal Disease | 324 | ||
Mucoid Impaction of Bronchi | 325 | ||
Bronchocentric Granulomatosis | 325 | ||
Chronic Obstructive Pulmonary Disease | 326 | ||
Emphysema | 326 | ||
Neuroendocrine Cell Hyperplasia With Occlusive Bronchiolar Fibrosis (Aguayo-Miller Disease) | 327 | ||
Diffuse Panbronchiolitis | 329 | ||
References | 330 | ||
Multiple-Choice Questions | 334.e1 | ||
Case 1 | 334.e2 | ||
Clinical History | 334.e2 | ||
Microscopic Pathology | 334.e2 | ||
Diagnosis | 334.e2 | ||
Comment | 334.e3 | ||
Bibliography | 334.e3 | ||
Case 2 | 334.e4 | ||
Clinical History | 334.e4 | ||
Microscopic Pathology | 334.e4 | ||
Diagnosis | 334.e4 | ||
Comment | 334.e4 | ||
Bibliography | 334.e5 | ||
Case 3 | 334.e5 | ||
Clinical History | 334.e5 | ||
Microscopic Pathology | 334.e5 | ||
Diagnosis | 334.e5 | ||
Comment | 334.e6 | ||
Bibliography | 334.e6 | ||
Case 4 | 334.e6 | ||
Clinical History | 334.e6 | ||
Microscopic Pathology | 334.e6 | ||
Diagnosis | 334.e8 | ||
Comment | 334.e8 | ||
Bibliography | 334.e8 | ||
Case 5 | 334.e8 | ||
Clinical History | 334.e8 | ||
Microscopic Pathology | 334.e8 | ||
Diagnosis | 334.e9 | ||
Comment | 334.e9 | ||
Bibliography | 334.e9 | ||
10 Pneumoconioses | 335 | ||
Overview and General Considerations | 335 | ||
Types of Pneumoconiosis | 335 | ||
Silicosis | 335 | ||
Clinical Presentation | 336 | ||
Pathologic Findings | 336 | ||
Differential Diagnosis | 337 | ||
Coal Workers’ Pneumoconiosis | 339 | ||
Clinical Presentation | 339 | ||
Pathologic Findings | 339 | ||
Differential Diagnosis | 342 | ||
Asbestosis | 342 | ||
Clinical Presentation | 342 | ||
Pathologic Findings | 343 | ||
Differential Diagnosis | 347 | ||
Silicatosis (Silicate Pneumoconiosis) | 347 | ||
Clinical Presentation | 347 | ||
Pathologic Findings | 347 | ||
Differential Diagnosis | 348 | ||
Talcosis (Talc Pneumoconiosis) | 349 | ||
Clinical Presentation | 349 | ||
Pathologic Findings | 349 | ||
Differential Diagnosis | 350 | ||
Siderosis | 351 | ||
Clinical Presentation | 351 | ||
Pathologic Findings | 351 | ||
Differential Diagnosis | 351 | ||
Aluminosis | 353 | ||
Clinical Presentation | 353 | ||
Pathologic Findings | 353 | ||
Differential Diagnosis | 354 | ||
Hard Metal Lung Disease | 354 | ||
Clinical Presentation | 354 | ||
Pathologic Findings | 355 | ||
Differential Diagnosis | 356 | ||
Berylliosis | 356 | ||
Clinical Presentation | 356 | ||
Pathologic Findings | 357 | ||
Differential Diagnosis | 357 | ||
Rare Earth Pneumoconiosis | 358 | ||
Clinical Presentation | 358 | ||
Pathologic Findings | 358 | ||
Differential Diagnosis | 358 | ||
Other Pneumoconioses | 358 | ||
References | 361 | ||
Multiple Choice Questions | 364.e1 | ||
Case 1 | 364.e2 | ||
eSlide 10.1 | 364.e2 | ||
Case 2 | 364.e2 | ||
eSlide 10.2 | 364.e2 | ||
Case 3 | 364.e2 | ||
eSlide 10.3 | 364.e2 | ||
Case 4 | 364.e3 | ||
eSlide 10.4 | 364.e3 | ||
Case 5 | 364.e3 | ||
eSlide 10.5 | 364.e3 | ||
11 Pulmonary Vasculitis and Pulmonary Hemorrhage | 365 | ||
Pulmonary Vasculitis | 365 | ||
Overview of Pulmonary Vasculitis | 365 | ||
Idiopathic Vasculitic Syndromes That Commonly Affect the Lung | 367 | ||
Granulomatosis With Polyangiitis (Wegener Granulomatosis) | 367 | ||
Clinical Features | 367 | ||
Laboratory Studies | 368 | ||
Radiologic Features | 369 | ||
Pathologic Features | 369 | ||
Differential Diagnosis | 374 | ||
Diagnosis | 377 | ||
Treatment and Prognosis | 377 | ||
Eosinophilic Granulomatosis With Polyangiitis/Churg-Strauss Syndrome | 377 | ||
Clinical Features | 378 | ||
Radiologic Features | 378 | ||
Pathologic Features | 379 | ||
Differential Diagnosis | 379 | ||
Treatment and Prognosis | 380 | ||
Microscopic Polyangiitis | 380 | ||
Clinical Features | 380 | ||
Radiographic Features | 381 | ||
Pathologic Features | 381 | ||
Differential Diagnosis | 381 | ||
Treatment and Prognosis | 382 | ||
Vasculitic Syndromes That Uncommonly Affect the Lung | 383 | ||
Necrotizing Sarcoid Granulomatosis | 383 | ||
Clinical Features | 383 | ||
Radiologic Features | 383 | ||
Pathologic Features | 383 | ||
Differential Diagnosis | 384 | ||
Treatment and Prognosis | 384 | ||
Giant Cell (Temporal) Arteritis | 384 | ||
Polyarteritis Nodosa | 387 | ||
Takayasu Arteritis | 387 | ||
Clinical Features | 387 | ||
Radiographic Features | 388 | ||
Pathologic Features | 388 | ||
Treatment | 388 | ||
Behçet Syndrome | 388 | ||
Clinical Features | 388 | ||
Radiographic Features | 389 | ||
Pathologic Features | 389 | ||
Treatment | 389 | ||
Secondary Vasculitis | 389 | ||
Pulmonary Infection and Septic Emboli | 389 | ||
Classic Sarcoidosis | 390 | ||
Radiologic Features | 390 | ||
Pathologic Features | 390 | ||
Therapy and Prognosis | 390 | ||
Pulmonary Hemorrhage | 390 | ||
Clinical View of Pulmonary Hemorrhage | 390 | ||
Morphologic Approach to Pulmonary Hemorrhage | 390 | ||
Diffuse Alveolar Hemorrhage | 393 | ||
Specific Forms of Diffuse Alveolar Hemorrhage | 394 | ||
Goodpasture Syndrome | 394 | ||
Granulomatosis With Polyangiitis (Wegener Granulomatosis) | 394 | ||
Microscopic Polyangiitis | 394 | ||
Systemic Lupus Erythematosus | 394 | ||
Idiopathic Pulmonary Hemosiderosis | 395 | ||
Henoch-Schönlein Purpura (IgA Vasculitis) | 395 | ||
Isolated Pulmonary Capillaritis | 397 | ||
References | 397 | ||
Multiple Choice Questions | 400.e1 | ||
Case 1 | 400.e3 | ||
Case 2 | 400.e3 | ||
Case 3 | 400.e4 | ||
Case 4 | 400.e4 | ||
Case 5 | 400.e4 | ||
12 Pulmonary Hypertension | 401 | ||
Morphologic Features of the Pulmonary Vasculature | 401 | ||
Pulmonary Arteries | 401 | ||
Pulmonary Veins | 402 | ||
Bronchial Arteries | 402 | ||
Recognition of Right Ventricular Hypertrophy | 402 | ||
Definition of Pulmonary Hypertension | 403 | ||
Classification of Pulmonary Hypertension | 403 | ||
Biomarkers of Pulmonary Hypertension | 404 | ||
Pathologic Features of Pulmonary Hypertension | 404 | ||
Plexogenic Arteriopathy | 404 | ||
Clinical and Etiologic Features | 404 | ||
Imaging Features | 404 | ||
Morphologic Features | 405 | ||
Grade I: Muscular Hypertrophy | 405 | ||
Grade II: Intimal Proliferation | 405 | ||
Grade III: Concentric Laminar Intimal Fibrosis | 405 | ||
Grade IV: Necrotizing Vasculitis | 405 | ||
Grade V: Plexiform Lesions | 405 | ||
Grade VI: Dilatation and Angiomatoid Lesions | 406 | ||
Clinical Correlations | 406 | ||
Differential Diagnosis | 407 | ||
Thrombotic and Embolic Hypertension | 410 | ||
Clinical Features | 410 | ||
Radiologic Features | 410 | ||
Pathologic Findings | 410 | ||
Clinical Correlations | 413 | ||
Differential Diagnosis | 413 | ||
Pulmonary Venous Hypertension | 413 | ||
Clinical Features | 413 | ||
Radiologic Features | 414 | ||
Pathologic Findings | 414 | ||
Clinical Correlations | 416 | ||
Differential Diagnosis | 416 | ||
Pulmonary Hypertension Secondary to Intrinsic Lung Disease or Hypoxia | 416 | ||
Morphologic Mimics of Pulmonary Hypertension | 417 | ||
Pathogenesis and Treatment of Pulmonary Hypertension | 417 | ||
References | 419 | ||
Multiple Choice Questions | 420.e1 | ||
13 Pathology of Lung Transplantation | 421 | ||
Operation-Related Complications | 422 | ||
Primary Graft Dysfunction | 422 | ||
Time Period | 422 | ||
Clinical Presentation | 422 | ||
Radiologic Findings | 422 | ||
Diagnosis | 422 | ||
Pathologic Findings | 422 | ||
Histologic Differential Diagnosis | 423 | ||
Treatment, Prognosis, and Prevention | 423 | ||
Arterial Anastomotic Obstruction | 423 | ||
14 Neuroendocrine Neoplasms of the Lung | 439 | ||
Introduction and General Considerations | 440 | ||
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia | 441 | ||
Definitions and Synonyms | 441 | ||
History | 441 | ||
Incidence and Demographics | 441 | ||
Clinical Manifestations | 441 | ||
Radiologic Features | 441 | ||
Gross Pathology | 441 | ||
Microscopic Pathology | 441 | ||
Special Studies | 442 | ||
Grading and Staging | 442 | ||
Differential Diagnosis | 442 | ||
Genetics | 443 | ||
Treatment and Prognosis | 443 | ||
Carcinoid Tumor | 443 | ||
Definitions and Synonyms | 443 | ||
Incidence and Demographics | 443 | ||
Clinical Manifestations | 443 | ||
Laboratory Findings | 443 | ||
Radiologic Features | 443 | ||
Gross Pathology | 444 | ||
Microscopic Pathology | 444 | ||
Special Studies | 446 | ||
Grading and Staging | 447 | ||
Variants | 447 | ||
Differential Diagnosis | 447 | ||
Genetics | 447 | ||
Treatment and Prognosis | 447 | ||
Atypical Carcinoid | 448 | ||
Definitions and Synonyms | 448 | ||
Incidence and Demographics | 448 | ||
Clinical Manifestations | 448 | ||
Laboratory Findings | 448 | ||
Radiologic Features | 448 | ||
Gross Pathology | 448 | ||
Microscopic Pathology | 448 | ||
Special Studies | 449 | ||
Grading and Staging | 449 | ||
Variants | 450 | ||
Differential Diagnosis | 450 | ||
Genetics | 450 | ||
Treatment and Prognosis | 450 | ||
Large Cell Neuroendocrine Carcinoma | 450 | ||
Definitions and Synonyms | 450 | ||
Incidence and Demographics | 450 | ||
Clinical Manifestations | 450 | ||
Laboratory Findings | 450 | ||
Radiologic Features | 451 | ||
Gross Pathology | 451 | ||
Microscopic Pathology | 451 | ||
Special Studies | 452 | ||
Grading and Staging | 452 | ||
Variants | 452 | ||
Differential Diagnosis | 452 | ||
Genetics | 453 | ||
Treatment and Prognosis | 453 | ||
Small Cell Carcinoma | 453 | ||
Definitions and Synonyms | 453 | ||
Incidence and Demographics | 455 | ||
Clinical Manifestations | 455 | ||
Laboratory Findings | 455 | ||
Radiologic Features | 455 | ||
Gross Pathology | 455 | ||
Microscopic Pathology | 455 | ||
Combined Type Small Cell Carcinoma | 457 | ||
Special Studies | 457 | ||
Grading and Staging | 457 | ||
Variants | 458 | ||
Differential Diagnosis | 458 | ||
Genetics | 458 | ||
Treatment and Prognosis | 459 | ||
Primitive Neuroectodermal Tumor | 459 | ||
Definitions and Synonyms | 459 | ||
Incidence and Demographics | 459 | ||
Clinical Manifestations | 459 | ||
Radiologic Features | 459 | ||
Gross Pathology | 459 | ||
Microscopic Pathology | 459 | ||
Special Studies | 459 | ||
Differential Diagnosis | 459 | ||
Genetics | 460 | ||
Treatment and Prognosis | 460 | ||
Other Rare Neuroendocrine Tumors | 460 | ||
References | 461 | ||
Multiple Choice Questions | 466.e1 | ||
Case 1 | 466.e4 | ||
eSlide 14.1 | 466.e4 | ||
15 Sarcomas and Sarcomatoid Neoplasms of the Lungs and Pleural Surfaces | 467 | ||
Part I. Sarcomatoid Carcinoma of the Lung | 467 | ||
Historical and Terminologic Considerations | 467 | ||
Clinicopathologic Features of Pulmonary Sarcomatoid Carcinomas | 468 | ||
Macroscopic Features | 468 | ||
Histologic Characteristics | 468 | ||
Homologous Biphasic Sarcomatoid Carcinomas. | 469 | ||
Heterologous Biphasic Sarcomatoid Carcinomas. | 469 | ||
Monophasic Sarcomatoid Carcinomas. | 469 | ||
Special Variants of Sarcomatoid Carcinoma of the Lung | 471 | ||
Pulmonary Blastoma | 471 | ||
Pseudoangiosarcomatous (Pseudovascular) Carcinoma | 472 | ||
Inflammatory Sarcomatoid Carcinoma | 472 | ||
Pleurotropic (Pseudomesotheliomatous) Sarcomatoid Carcinoma | 473 | ||
Results of Adjunctive Pathologic Studies | 475 | ||
Differential Diagnosis of Sarcomatoid Carcinoma | 476 | ||
Part II: True Primary Sarcomas of the Lung | 476 | ||
Kaposi Sarcoma | 476 | ||
Clinical Summary | 476 | ||
Pathologic Findings | 477 | ||
Therapy and Prognosis | 477 | ||
Fibrosarcoma | 477 | ||
Clinical Summary | 478 | ||
Pathologic Findings | 478 | ||
Therapy and Prognosis | 479 | ||
Primary Pulmonary Hyalinizing Spindle-Cell Tumor With Giant Rosettes. | 479 | ||
Primary Pulmonary Leiomyosarcoma | 479 | ||
Clinical Summary | 480 | ||
Pathologic Findings | 480 | ||
Therapy and Prognosis | 482 | ||
Epithelioid Hemangioendothelioma | 482 | ||
Clinical Summary | 482 | ||
Pathologic Findings | 482 | ||
Therapy and Prognosis | 485 | ||
Hemangiopericytoma and Intrapulmonary Solitary Fibrous Tumor | 485 | ||
Clinical Summary | 485 | ||
Pathologic Findings | 486 | ||
Therapy and Prognosis | 487 | ||
Malignant Fibrous Histiocytoma | 487 | ||
Clinical Summary | 487 | ||
Pathologic Findings | 487 | ||
Therapy and Prognosis | 488 | ||
Rhabdomyosarcoma | 488 | ||
Clinical Summary | 488 | ||
Pathologic Findings | 488 | ||
Therapy and Prognosis | 489 | ||
Chondrosarcoma of the Respiratory Tract | 489 | ||
Clinical Summary | 489 | ||
Pathologic Findings | 491 | ||
Therapy and Prognosis | 491 | ||
Primary Pulmonary Synovial Sarcoma | 491 | ||
Clinical Findings | 491 | ||
Pathologic Findings | 494 | ||
Therapy and Prognosis | 496 | ||
Other Primary Pulmonary Sarcomas | 496 | ||
Part III: Primary Malignant Melanomas of the Lung | 497 | ||
Clinical Summary | 497 | ||
Pathologic Findings | 497 | ||
Therapy and Prognosis | 500 | ||
Part IV: Sarcomas of the Pulmonary Arterial Trunk | 500 | ||
Clinical Summary | 501 | ||
Pathologic Findings | 501 | ||
Therapy and Prognosis | 502 | ||
Part V: Tumors of the Pleura | 503 | ||
Sarcomatoid Malignant Mesothelioma (See Also Chapter 21) | 503 | ||
Clinical Summary | 503 | ||
Pathologic Findings | 504 | ||
Therapy and Prognosis | 505 | ||
Primary Pleural Sarcomas | 506 | ||
Pleural Fibrosarcoma and Malignant Solitary Fibrous Tumor | 506 | ||
Clinical Summary | 506 | ||
Pathologic Findings | 507 | ||
Therapy and Prognosis | 508 | ||
Primary Pleural Leiomyosarcoma | 509 | ||
Clinical Summary | 509 | ||
Pathologic Findings | 509 | ||
Therapy and Prognosis | 509 | ||
Askin Tumor (Primitive Neuroectodermal Tumor) and Desmoplastic Small Round-Cell Tumor | 510 | ||
Clinical Summary | 510 | ||
Pathologic Findings | 510 | ||
Therapy and Prognosis | 512 | ||
Pleuropulmonary Blastoma | 513 | ||
Clinical Summary | 514 | ||
Pathologic Findings | 514 | ||
Therapy and Prognosis | 516 | ||
Vascular Sarcomas of the Pleura | 517 | ||
References | 519 | ||
Multiple Choice Questions | 526.e1 | ||
Case 1 | 526.e3 | ||
eSlide 15.1 | 526.e3 | ||
16 Hematolymphoid Disorders | 527 | ||
Special Studies | 527 | ||
Immunohistochemistry | 527 | ||
Indications | 527 | ||
17 Nonneuroendocrine Carcinomas (Excluding Sarcomatoid Carcinoma) and Salivary Gland Analogue Tumors of the Lung | 573 | ||
Incidence | 573 | ||
Demographics | 573 | ||
Prognosis | 573 | ||
Etiology | 573 | ||
Lung Cancer Clinical Findings and Imaging | 574 | ||
Clinical Findings | 574 | ||
Imaging | 574 | ||
Lung Cancer Staging, Prognosis, and Traditional Therapy | 574 | ||
Staging | 574 | ||
Prognosis | 575 | ||
Traditional Therapy | 575 | ||
Lung Cancer Histology | 575 | ||
Overview of Lung Cancer Histology | 575 | ||
2015 World Health Organization Classification of Lung Cancer | 575 | ||
Adenocarcinoma | 576 | ||
Lepidic Pattern and Bronchioloalveolar Carcinoma | 576 | ||
Atypical Adenomatous Hyperplasia | 577 | ||
Adenocarcinoma in situ | 577 | ||
Minimally Invasive Adenocarcinoma | 578 | ||
Invasive Adenocarcinoma | 578 | ||
Lepidic Adenocarcinoma | 578 | ||
Acinar Adenocarcinoma | 579 | ||
Papillary Adenocarcinoma | 579 | ||
Micropapillary Adenocarcinoma | 579 | ||
Solid Adenocarcinoma | 579 | ||
Invasive Mucinous Adenocarcinoma | 579 | ||
Colloid Adenocarcinoma | 580 | ||
Fetal Adenocarcinoma | 580 | ||
Enteric Adenocarcinoma | 581 | ||
Signet Ring and Clear Cell Features | 581 | ||
Squamous Cell Carcinoma | 581 | ||
Adenosquamous Carcinoma | 583 | ||
Large Cell Carcinoma | 583 | ||
Minor Cell Types (Including Salivary Gland and Sarcomatoid Types) | 584 | ||
Sarcomatoid Type. | 584 | ||
Carcinosarcoma. | 584 | ||
Blastoma. | 584 | ||
Pleomorphic Carcinoma. | 584 | ||
Salivary Gland Type. | 585 | ||
Adenoid Cystic Carcinoma. | 585 | ||
Mucoepidermoid Carcinoma. | 585 | ||
Epithelial-Myoepithelial Carcinoma. | 586 | ||
Lymphoepithelioma-Like Carcinoma. | 586 | ||
Nuclear Protein in Testis Carcinoma. | 586 | ||
Cytology | 586 | ||
Adenocarcinoma | 587 | ||
Squamous Cell Carcinoma | 588 | ||
Salivary Gland-Like Tumors | 591 | ||
Other Neoplasms | 592 | ||
Targeted Therapy Biomarkers in Lung Cancer | 592 | ||
Immune Checkpoint Therapies in Lung Cancer | 592 | ||
References | 593 | ||
Multiple Choice Questions | 596.e1 | ||
Case 1: Pulmonary Adenocarcinoma Carcinoma | 596.e3 | ||
eSlide 17.1 | 596.e3 | ||
18 Metastatic Tumors in the Lung | 597 | ||
Routes of Spread for Intrapulmonary Metastases | 597 | ||
Vascular Metastases | 597 | ||
Lymphogenous Metastases | 599 | ||
Direct Seeding | 600 | ||
Pleural Metastases | 600 | ||
Endobronchial Metastases | 601 | ||
Modalities for the Diagnosis of Pleuropulmonary Metastases | 603 | ||
Practical Approach to Differential Diagnosis | 604 | ||
Adenocarcinoma Variants | 606 | ||
Papillary Adenocarcinomas | 606 | ||
Clear Cell Adenocarcinomas | 607 | ||
Signet-Ring Cell Adenocarcinomas | 609 | ||
Well-Differentiated Adenocarcinomas | 609 | ||
Oncocytic and Granular Cell Carcinomas | 612 | ||
Largely Necrotic Adenocarcinomas | 614 | ||
Mucinous Adenocarcinomas | 614 | ||
Other Metastatic Malignancies That Mimic Adenocarcinomas of the Lung | 616 | ||
Malignant Small Round Cell Tumors | 621 | ||
Squamous Cell Carcinomas and Morphologic Simulants | 623 | ||
Undifferentiated Large Polygonal Cell Malignancies | 627 | ||
Other Adjunctive Pathologic Techniques for the Diagnosis of Metastatic Carcinoma | 629 | ||
Outcomes Analysis | 633 | ||
References | 639 | ||
Multiple Choice Questions | 642.e1 | ||
19 Pseudoneoplastic Lesions of the Lungs and Pleural Surfaces | 643 | ||
Pulmonary Hamartoma | 643 | ||
Inflammatory Pseudotumor—Plasma Cell Granuloma of the Lung | 646 | ||
Mycobacterial Spindle-Cell Pseudotumor | 649 | ||
Pseudoneoplastic Hematolymphoid Processes | 650 | ||
Rosai-Dorfman Disease (Sinus Histiocytosis With Massive Lymphadenopathy) | 650 | ||
Extramedullary Hematopoiesis | 651 | ||
Pseudoneoplastic Changes as a Consequence of Lung Injury | 653 | ||
Peribronchiolar Metaplasia (Lambertosis) | 654 | ||
Pseudoneoplastic Lesions of the Pleural Surfaces | 655 | ||
Reactive Mesothelial Proliferations | 656 | ||
Tumefactive Hyaline Pleural Plaques | 658 | ||
Diffuse Pleural Fibrosis | 659 | ||
References | 660 | ||
Multiple Choice Questions | 664.e1 | ||
Case 1 | 664.e3 | ||
eSlide 19.1 | 664.e3 | ||
20 Benign and Borderline Tumors of the Lungs and Pleura | 665 | ||
Benign Pleuropulmonary Neoplasms | 665 | ||
Clinical Features | 665 | ||
Benign Tumors That Are Principally Tracheal and Endobronchial | 666 | ||
Solitary Tracheobronchial Papilloma | 666 | ||
Multifocal Respiratory Tract Papillomatosis | 667 | ||
Bronchial Mucous Gland Adenoma | 668 | ||
Salivary Gland Analog Tumors | 671 | ||
Mixed Tumor (Pleomorphic Adenoma) | 671 | ||
Oncocytoma | 671 | ||
Peripheral Nerve Sheath Tumors | 674 | ||
Granular Cell Tumors | 677 | ||
Benign Lesions Affecting Either the Airways or the Lung Parenchyma | 679 | ||
Alveolar Adenoma | 679 | ||
Papillary Adenoma | 681 | ||
Leiomyoma | 681 | ||
Glomus Tumor and Glomangioma | 681 | ||
Chondroma, Myxoma, and Fibromyxoma | 685 | ||
Solitary Pulmonary Hemangioma and Hemangiomatosis | 685 | ||
Lipoma and Lipoblastoma | 686 | ||
Angiomyolipoma | 688 | ||
Myelolipoma | 689 | ||
Benign Tumors of the Pleura | 689 | ||
Adenomatoid Tumor | 689 | ||
Calcifying Fibrous Pseudotumor | 691 | ||
Leiomyoma | 692 | ||
Biologically Borderline Tumors of the Lung and Pleura | 692 | ||
Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) | 692 | ||
Sclerosing Hemangioma (Pneumocytoma) | 695 | ||
Pulmonary Mucinous Cystadenoma and Borderline Mucinous Tumor | 698 | ||
Solitary Fibrous Tumor | 700 | ||
Desmoid Tumor | 703 | ||
Clear Cell Tumor | 705 | ||
Primary Pleuropulmonary Thymoma | 705 | ||
Heterotopic Meningeal Proliferations | 710 | ||
Intrapulmonary Teratomas | 713 | ||
Cystic Fibrohistiocytic Tumor of the Lung | 714 | ||
Other Lesions | 715 | ||
References | 715 | ||
Multiple Choice Questions | 722.e1 | ||
Case 1 | 722.e2 | ||
eSlide 20.1 | 722.e2 | ||
21 Malignant and Borderline Mesothelial Tumors of the Pleura | 723 | ||
Malignant Mesothelioma | 723 | ||
Clinical Findings in Pleural Mesothelioma | 723 | ||
Etiologic Considerations in Pleural Mesothelioma | 725 | ||
Gross Features of Pleural Mesothelioma | 727 | ||
Cytopathologic Features of Pleural Mesothelioma | 727 | ||
Histopathologic Features of Pleural Mesothelioma | 730 | ||
Epithelioid Mesothelioma | 731 | ||
Sarcomatoid (Spindle Cell) Mesothelioma | 732 | ||
Desmoplastic Mesothelioma | 733 | ||
Biphasic Mesothelioma | 736 | ||
Small Cell Mesothelioma | 736 | ||
Rhabdoid Mesothelioma | 736 | ||
Localized (Solitary) Mesothelioma | 737 | ||
Histochemical Features of Pleural Mesothelioma | 737 | ||
Electron Microscopic Features of Pleural Mesothelioma | 738 | ||
Immunohistochemical Findings in Pleural Mesothelioma | 739 | ||
Antibodies Often Used in the Analysis of Possible Mesothelioma | 741 | ||
General and Exclusionary Markers | 741 | ||
Keratins. | 741 | ||
Epithelial Membrane Antigen. | 741 | ||
Carcinoembryonic Antigen. | 741 | ||
Thyroid Transcription Factor-1. | 742 | ||
Napsin-A. | 742 | ||
CD15. | 742 | ||
CA 72-4. | 742 | ||
Ber-Ep4. | 742 | ||
MOC-31. | 742 | ||
BG8. | 742 | ||
p53. | 742 | ||
Inclusionary Markers | 742 | ||
Calretinin. | 742 | ||
WT1 Gene Product. | 742 | ||
Thrombomodulin. | 743 | ||
Podoplanin. | 743 | ||
Other Markers | 744 | ||
Oncofetal Proteins. | 744 | ||
Blood Group Isoantigens. | 744 | ||
Mesothelin. | 744 | ||
HBME-1 and Cancer Antigen 125. | 744 | ||
Neuroendocrine Determinants. | 744 | ||
Additional Hematopoietic Markers. | 744 | ||
Anti-BAP-1, p16, and Other Supplementary Reagents. | 745 | ||
Practical Points Regarding the Immunohistochemistry of Mesothelioma | 745 | ||
Cytogenetic and Molecular Features of Pleural Mesothelioma | 745 | ||
Differential Diagnosis of Pleural Mesothelioma: Special Considerations | 746 | ||
Differential Diagnosis of Benign Versus Malignant Mesothelial Proliferations | 746 | ||
Florid Mesothelial Hyperplasia Versus Epithelioid Mesothelioma. | 746 | ||
Fibrohyaline Pleuritis Versus Desmoplastic Mesothelioma. | 746 | ||
Differential Diagnosis of Cytologically Malignant Pleural Neoplasms | 747 | ||
Epithelioid Mesothelioma Versus Hematopoietic Malignancies. | 747 | ||
Epithelioid Mesothelioma Versus Epithelioid Endothelial Neoplasms. | 748 | ||
Primary Pleural Myxoid Chondrosarcoma Versus Mesothelioma. | 748 | ||
Synovial Sarcoma Versus Mesothelioma. | 749 | ||
Pseudomesotheliomatous Sarcomatoid Carcinoma Versus Mesothelioma. | 749 | ||
Small Cell Mesothelioma Versus Other Small Cell Malignancies. | 750 | ||
Primary Pleural Thymomatosis Versus Mesothelioma. | 750 | ||
Solitary Fibrous Tumor of the Pleura Versus Sarcomatoid Mesothelioma. | 751 | ||
Clear Cell Mesothelioma Versus Metastatic Renal Cell Carcinoma. | 751 | ||
Oncocytoid/Deciduoid Mesothelioma Versus Other “Pink” Cell Malignancies. | 751 | ||
Rhabdoid Mesothelioma Versus Metastases of Extrarenal Malignant Rhabdoid Tumors. | 752 | ||
Epithelioid Mesothelioma Versus Primary or Metastatic Germ Cell Malignancies. | 752 | ||
Metastatic Intranodal Mesothelioma Versus Lymph Nodal Mesothelial Rests. | 752 | ||
Borderline (Low-Grade Malignant) Mesothelial Tumors | 752 | ||
Etiologic Considerations | 753 | ||
Clinical Findings | 753 | ||
Pathologic Observations | 753 | ||
Staging and Prognosis of Malignant Mesothelioma | 754 | ||
References | 755 | ||
Multiple Choice Questions | 762.e1 | ||
Case 1 | 762.e3 | ||
eSlide 21.1 | 762.e3 | ||
Case 2 | 762.e3 | ||
eSlide 21.2 | 762.e3 | ||
Case 3 | 762.e3 | ||
eSlide 21.3 | 762.e3 | ||
Case 4 | 762.e3 | ||
eSlide 21.4 | 762.e3 | ||
Case 5 | 762.e3 | ||
eSlide 21.5 | 762.e3 | ||
Appendix: Miscellaneous Distinctive Histopathologic Findings | 763 | ||
Index | 781 | ||
A | 781 | ||
B | 784 | ||
C | 785 | ||
D | 789 | ||
E | 790 | ||
F | 791 | ||
G | 792 | ||
H | 793 | ||
I | 794 | ||
K | 796 | ||
L | 796 | ||
M | 798 | ||
N | 800 | ||
O | 802 | ||
P | 802 | ||
R | 807 | ||
S | 807 | ||
T | 810 | ||
U | 811 | ||
V | 811 | ||
W | 811 | ||
X | 811 | ||
Y | 811 | ||
Z | 811 | ||
Inside Back Cover | ibc1 |